$132 Million is the total value of Fiera Capital (Europe) Ltd.'s 66 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITUB | Sell | ITAU UNIBANCO HOLDINGS SAsponsored adr rep pfd | $20,106,000 | -0.3% | 1,352,552 | -8.9% | 15.23% | +34.6% |
| BIDU | Sell | BAIDU INCspon adr rep a | $17,361,000 | -21.8% | 114,229 | -8.8% | 13.15% | +5.6% |
| VALE | Sell | VALE S Aadr | $12,367,000 | -34.1% | 894,566 | -27.4% | 9.37% | -11.0% |
| FMX | Buy | FOMENTO ECONOMICO MEXICANO Ssponsored adr units | $9,788,000 | +25.5% | 105,116 | +31.7% | 7.41% | +69.5% |
| ABEV | Sell | AMBEV SAsponsored adr | $9,551,000 | -3.6% | 1,288,132 | -4.4% | 7.24% | +30.2% |
| PBRA | Sell | PETROLEO BRASILEIRO SA PETROsp adr non vtg | $8,360,000 | -24.4% | 603,815 | -19.7% | 6.33% | +2.1% |
| CTCM | Sell | CTC MEDIA INC | $7,889,000 | -44.8% | 856,111 | -16.7% | 5.98% | -25.4% |
| EDU | Sell | NEW ORIENTAL ED & TECH GRP Isponsored adr | $7,876,000 | -23.9% | 268,065 | -18.4% | 5.97% | +2.8% |
| CCU | Sell | COMPANIA CERVECERIAS UNIDASsponsored adr | $7,369,000 | -12.7% | 329,696 | -5.9% | 5.58% | +17.9% |
| BBD | Sell | BANCO BRADESCO S Asp adr pfd new | $5,013,000 | +2.0% | 366,589 | -6.6% | 3.80% | +37.7% |
| TV | Sell | GRUPO TELEVISA SAsponsored adr rep ord | $4,861,000 | -3.8% | 145,958 | -12.4% | 3.68% | +29.9% |
| BAP | Sell | CREDICORP LTD | $4,364,000 | -3.4% | 31,773 | -6.8% | 3.31% | +30.4% |
| BRFS | Sell | BRF SAsponsored adr | $3,383,000 | -5.5% | 169,625 | -1.1% | 2.56% | +27.6% |
| CPA | Sell | COPA HOLDINGS SAcl a | $3,241,000 | -43.0% | 20,267 | -43.0% | 2.46% | -23.1% |
| GRAM | Sell | GRANA Y MONTERO S A Asponsored adr | $2,609,000 | -20.4% | 150,930 | -2.2% | 1.98% | +7.5% |
| AVHOQ | New | AVIANCA HLDGS SAspon adr rep pfd | $1,705,000 | – | 100,532 | +100.0% | 1.29% | – |
| JNJ | Buy | JOHNSON & JOHNSON | $602,000 | +118.9% | 6,125 | +103.6% | 0.46% | +196.1% |
| PFE | Buy | PFIZER INC | $596,000 | +14.8% | 18,553 | +9.6% | 0.45% | +55.0% |
| PBR | Sell | PETROLEO BRASILEIRO SA PETROsponsored adr | $485,000 | -52.4% | 36,921 | -50.0% | 0.37% | -35.8% |
| MRK | Buy | MERCK & CO INC NEW | $378,000 | +33.1% | 6,649 | +16.9% | 0.29% | +79.9% |
| GGB | Sell | GERDAU S Asponsored adr rep pfd | $370,000 | -19.0% | 57,556 | -1.2% | 0.28% | +9.4% |
| CZZ | New | COSAN LTD | $260,000 | – | 22,784 | +100.0% | 0.20% | – |
| AGN | Buy | ALLERGAN INC | $234,000 | +114.7% | 1,891 | +93.8% | 0.18% | +190.2% |
| PODD | New | INSULET CORP | $231,000 | – | 4,868 | +100.0% | 0.18% | – |
| ABBV | Buy | ABBVIE INC | $204,000 | +2.5% | 3,964 | +5.3% | 0.16% | +38.4% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $198,000 | +38.5% | 3,822 | +41.6% | 0.15% | +87.5% |
| OREX | New | OREXIGEN THERAPEUTICS INC | $182,000 | – | 28,299 | +100.0% | 0.14% | – |
| GILD | Sell | GILEAD SCIENCES INC | $177,000 | -21.3% | 2,502 | -16.7% | 0.13% | +6.3% |
| MYL | Buy | MYLAN INC | $170,000 | +169.8% | 3,485 | +140.2% | 0.13% | +268.6% |
| MDT | Buy | MEDTRONIC INC | $167,000 | +77.7% | 2,718 | +65.6% | 0.13% | +137.7% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $155,000 | – | 1,286 | +100.0% | 0.12% | – |
| MDVN | Buy | MEDIVATION INC | $148,000 | +362.5% | 2,294 | +357.9% | 0.11% | +522.2% |
| ILMN | ILLUMINA INC | $142,000 | +35.2% | 952 | 0.0% | 0.11% | +83.1% | |
| SNY | SANOFIsponsored adr | $142,000 | -1.4% | 2,700 | 0.0% | 0.11% | +33.3% | |
| THRX | Buy | THERAVANCE INC | $140,000 | +55.6% | 4,352 | +71.7% | 0.11% | +112.0% |
| AMGN | Sell | AMGEN INC | $131,000 | -16.6% | 1,065 | -22.8% | 0.10% | +12.5% |
| FRX | Buy | FOREST LABS INC | $117,000 | +74.6% | 1,269 | +14.1% | 0.09% | +134.2% |
| SLXP | Buy | SALIX PHARMACEUTICALS INC | $110,000 | +233.3% | 1,068 | +188.6% | 0.08% | +336.8% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $85,000 | – | 4,081 | +100.0% | 0.06% | – |
| BDX | New | BECTON DICKINSON & CO | $82,000 | – | 697 | +100.0% | 0.06% | – |
| ABT | Buy | ABBOTT LABS | $75,000 | +17.2% | 1,940 | +16.0% | 0.06% | +58.3% |
| BIIB | Sell | BIOGEN IDEC INC | $72,000 | -41.0% | 236 | -45.9% | 0.06% | -19.1% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $70,000 | -22.2% | 233 | -28.3% | 0.05% | +6.0% |
| P103PS | New | NPS PHARMACEUTICALS INC | $56,000 | – | 1,876 | +100.0% | 0.04% | – |
| ARWR | Sell | ARROWHEAD RESH CORP | $54,000 | -86.6% | 3,305 | -91.1% | 0.04% | -81.9% |
| PCYC | New | PHARMACYCLICS INC | $52,000 | – | 519 | +100.0% | 0.04% | – |
| CVD | Buy | COVANCE INC | $50,000 | +51.5% | 842 | +124.5% | 0.04% | +100.0% |
| Q | Buy | QUINTILES TRANSNATIO HLDGS I | $49,000 | +40.0% | 973 | +30.4% | 0.04% | +85.0% |
| CELG | Sell | CELGENE CORP | $49,000 | -48.4% | 348 | -38.2% | 0.04% | -30.2% |
| CBST | Buy | CUBIST PHARMACEUTICALS INC | $45,000 | +36.4% | 612 | +28.3% | 0.03% | +78.9% |
| BAX | Sell | BAXTER INTL INC | $37,000 | -52.6% | 499 | -55.5% | 0.03% | -36.4% |
| WAT | WATERS CORP | $34,000 | +6.2% | 315 | 0.0% | 0.03% | +44.4% | |
| MDCO | New | MEDICINES CO | $27,000 | – | 970 | +100.0% | 0.02% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -718 | -100.0% | -0.02% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -446 | -100.0% | -0.02% | – |
| LIFE | Exit | LIFE TECHNOLOGIES CORP | $0 | – | -414 | -100.0% | -0.02% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -2,761 | -100.0% | -0.02% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -4,300 | -100.0% | -0.02% | – |
| UGP | Exit | ULTRAPAR PARTICIPACOES S A | $0 | – | -43,587 | -100.0% | -0.58% | – |
| MBT | Exit | MOBILE TELESYSTEMS OJSCsponsored adr | $0 | – | -453,355 | -100.0% | -5.50% | – |
| BSAC | Exit | BANCO SANTANDER CHILE NEW | $0 | – | -520,587 | -100.0% | -6.87% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JD.COM ADR | 16 | Q1 2017 | 18.4% |
| GENOMIC HEALTH INC | 16 | Q1 2017 | 9.1% |
| PFIZER INC | 16 | Q1 2017 | 13.5% |
| FOMENTO ECONOMIC ADR | 16 | Q1 2017 | 5.1% |
| BRISTOL MYERS SQUIBB | 16 | Q1 2017 | 4.8% |
| BECTON DICKINSON | 15 | Q1 2017 | 21.4% |
| AMGEN INC | 14 | Q1 2017 | 9.3% |
| BRASIL FOODS ADR | 14 | Q1 2017 | 8.1% |
| VALE S A | 14 | Q1 2017 | 13.5% |
| PHARMACYCLICS INC | 14 | Q1 2017 | 0.8% |
View Fiera Capital (Europe) Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-13 |
| 13F-NT | 2023-11-02 |
| 13F-NT | 2023-08-08 |
| 13F-NT | 2023-05-09 |
| 13F-NT | 2023-02-13 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-09 |
| 13F-NT | 2022-05-16 |
| 13F-NT | 2022-02-11 |
| 13F-NT | 2021-11-12 |
View Fiera Capital (Europe) Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.